These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 9802335)
1. Reduced DNA synthesis and cell viability in small cell lung carcinoma by treatment with cyclic AMP phosphodiesterase inhibitors. Shafer SH; Phelps SH; Williams CL Biochem Pharmacol; 1998 Nov; 56(9):1229-36. PubMed ID: 9802335 [TBL] [Abstract][Full Text] [Related]
2. The neurotoxin 1-methyl-4-phenylpyridinium: a selective cytostatic agent in small-cell lung cancer cell lines with neuroendocrine properties. Marini AM; Fridman R; Kanemoto T; Martin GR; Guo Y; Passaniti A J Natl Cancer Inst; 1992 Oct; 84(20):1582-7. PubMed ID: 1328660 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of pig aortic smooth muscle cell DNA synthesis by selective type III and type IV cyclic AMP phosphodiesterase inhibitors. Souness JE; Hassall GA; Parrott DP Biochem Pharmacol; 1992 Sep; 44(5):857-66. PubMed ID: 1326964 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of platelet-derived growth factor-induced mitogenesis by phosphodiesterase 3 inhibitors: role of protein kinase A in vascular smooth muscle cell mitogenesis. Osinski MT; Schrör K Biochem Pharmacol; 2000 Aug; 60(3):381-7. PubMed ID: 10856433 [TBL] [Abstract][Full Text] [Related]
5. Caffeine promotes survival of cultured sympathetic neurons deprived of nerve growth factor through a cAMP-dependent mechanism. Tanaka S; Koike T Biochim Biophys Acta; 1992 Dec; 1175(1):114-22. PubMed ID: 1336398 [TBL] [Abstract][Full Text] [Related]
6. Circadian periodicity a neurospora: alteration by inhibitors of cyclic AMP phosphodiesterase. Feldman JF Science; 1975 Nov; 190(4216):789-90. PubMed ID: 173018 [TBL] [Abstract][Full Text] [Related]
7. Caffeine eliminates gamma-ray-induced G2-phase delay in human tumor cells but not in normal cells. Jha MN; Bamburg JR; Bernstein BW; Bedford JS Radiat Res; 2002 Jan; 157(1):26-31. PubMed ID: 11754638 [TBL] [Abstract][Full Text] [Related]
8. Small cell lung carcinoma exhibits greater phospholipase C-beta1 expression and edelfosine resistance compared with non-small cell lung carcinoma. Strassheim D; Shafer SH; Phelps SH; Williams CL Cancer Res; 2000 May; 60(10):2730-6. PubMed ID: 10825148 [TBL] [Abstract][Full Text] [Related]
9. The effects of phosphodiesterase inhibition on cyclic GMP and cyclic AMP accumulation in the hippocampus of the rat. van Staveren WC ; Markerink-van Ittersum M ; Steinbusch HW; de Vente J Brain Res; 2001 Jan; 888(2):275-286. PubMed ID: 11150485 [TBL] [Abstract][Full Text] [Related]
10. Possible Contribution of Prostaglandin E2 to the antiproliferative effect of phosphodiesterase 4 inhibitors in human mononuclear cells. Banner KH; Hoult JR; Taylor MN; Landells LJ; Page CP Biochem Pharmacol; 1999 Nov; 58(9):1487-95. PubMed ID: 10513992 [TBL] [Abstract][Full Text] [Related]
11. Carboxyamidotriazole: a novel inhibitor of both cAMP-phosphodiesterases and cGMP-phosphodiesterases. Guo L; Luo L; Ju R; Chen C; Zhu L; Li J; Yu X; Ye C; Zhang D Eur J Pharmacol; 2015 Jan; 746():14-21. PubMed ID: 25446933 [TBL] [Abstract][Full Text] [Related]
14. Tissue selective inhibition of cyclic nucleotide phosphodiesterase by denbufylline. Wilke R; Arch JR; Nicholson CD Arzneimittelforschung; 1989 Jun; 39(6):665-7. PubMed ID: 2476135 [TBL] [Abstract][Full Text] [Related]
15. Muscarinic signaling in carcinoma cells. Williams CL Life Sci; 2003 Mar; 72(18-19):2173-82. PubMed ID: 12628476 [TBL] [Abstract][Full Text] [Related]
16. Effect of different xanthines and phosphodiesterase inhibitors on c-fos expression in rat striatum. Svenningsson P; Johansson B; Fredholm BB Acta Physiol Scand; 1995 May; 154(1):17-24. PubMed ID: 7572198 [TBL] [Abstract][Full Text] [Related]
17. Selective effects of phosphodiesterase inhibitors on different phosphodiesterases, adenosine 3',5'-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes. Elks ML; Manganiello VC Endocrinology; 1984 Oct; 115(4):1262-8. PubMed ID: 6207009 [TBL] [Abstract][Full Text] [Related]
18. The interaction of 4-alkyl derivatives of 2,6,7-trioxa-1-phosphabicyclo [2,2,2] octanes with cyclic adenosine 3',5'-monophosphate phosphodiesterase, and with cyclic adenosine 3',5'-monophosphate binding proteins. Coult DB; Wilkinson RG Biochem Pharmacol; 1977 May; 26(9):887-9. PubMed ID: 193519 [No Abstract] [Full Text] [Related]
19. Low doses of cyclic AMP-phosphodiesterase inhibitors rapidly evoke opioid receptor-mediated thermal hyperalgesia in naïve mice which is converted to prominent analgesia by cotreatment with ultra-low-dose naltrexone. Crain SM; Shen KF Brain Res; 2008 Sep; 1231():16-24. PubMed ID: 18656459 [TBL] [Abstract][Full Text] [Related]
20. Vasoactive intestinal peptide inhibits human small-cell lung cancer proliferation in vitro and in vivo. Maruno K; Absood A; Said SI Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14373-8. PubMed ID: 9826707 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]